Former FDA head Stephen Hahn joins radiopharmaceuticals startup as CEO News Former FDA head Stephen Hahn joins radiopharmaceuticals startup as CEO
Nucleus RadioPharma Appoints Former FDA Commissioner Dr. Stephen Hahn as CEO to Scale Patient Access to Radiopharmaceutical Therapies News Nucleus RadioPharma Appoints Former FDA Commissioner Dr. Stephen Hahn as CEO to Scale Patient Access to Radiopharmaceutical Therapies
Get ahead of CMC hurdles before they derail your IND Industry Insights Get ahead of CMC hurdles before they derail your IND
How we’re solving one of radiopharma’s biggest barriers to adoption Industry Insights How we’re solving one of radiopharma’s biggest barriers to adoption
A New Theranostic System Designed for Radiopharma’s Real-World Demands News A New Theranostic System Designed for Radiopharma’s Real-World Demands
Facet Life Sciences Announces Partnership with Nucleus RadioPharma as Official Regulatory Partner News Facet Life Sciences Announces Partnership with Nucleus RadioPharma as Official Regulatory Partner
Ask the right questions at every stage to keep your radiopharmaceutical on track Industry Insights Ask the right questions at every stage to keep your radiopharmaceutical on track
How to prepare your radiotherapeutic for success at scale Industry Insights How to prepare your radiotherapeutic for success at scale
Five key considerations for the administration of your radiopharmaceutical therapy Industry Insights Five key considerations for the administration of your radiopharmaceutical therapy
Backed by AstraZeneca, this company is helping radioligand cancer therapies hit the shelves News Backed by AstraZeneca, this company is helping radioligand cancer therapies hit the shelves
